GERN vs MMC · rev $109.3M vs P/E 22, rev $26.98B
Geron Corporation (GERN) versus Marsh & McLennan Companies Inc (MMC) — a side-by-side from cached financials, not a winner call.
Geron Corporation (GERN) is a biotechnology company listed on US.
Marsh & McLennan Companies Inc (MMC) is a insurance brokers company listed on US.
Latest reported GERN revenue for 2026-06-30 was $109.3M. Net income was -$20.3M. GERN currently screens at market cap $878.9M.
Latest reported MMC revenue for 2025-12-31 was $26.98B. Net income was $4.16B. Revenue was up 10.3% from 2024-12-31 to 2025-12-31. MMC currently screens at market cap $89.82B and trailing P/E 21.9.
GERN currently screens at market cap $878.9M. MMC currently screens at market cap $89.82B and trailing P/E 21.9.
Not investment advice. Open the GERN and MMC stock pages for the full models.
Not investment advice.